Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A
Casteels, K.; Waer, M.; Bouillon, R.; Allewaert, K.; Laureys, J.; Mathieu, C.
Transplantation Proceedings 28(6): 3095
1996
ISSN/ISBN: 0041-1345 PMID: 8962198 Document Number: 462042
Document emailed within 1 workday
Related Documents
Tuomilehto, J.; Lindström, J. 2003: The principal trials for prevention of type 2 diabetes have now confirmed that type 2 diabetes can be prevented by life style changes. Prevention of type 2 diabetes by life style Journees Annuelles de Diabetologie de l'Hotel-Dieu 2003: 77-89Philippe, J. 2009: Role and indication of GLP-1 analogues in the treatment of type 2 diabetes Revue Medicale Suisse 5(206): 1260-1262; 1264-1265
Schernthaner, G.; Aschauer-Treiber, G.; Gaube, S.; Klösch-Kasparek, D.; Müller, C.; Zielinski, C. 1988: Results of cyclosporin a therapy in the early phase of type i diabetes mellitus Wiener Klinische Wochenschrift 100(13): 454-459
Zhang, S.; Dong, W.L.; Mao, F.; Jiang, Y.Y.; Wu, L.; Lou, Q.L.; Wu, H.D.; Zhang, Y.Q.; Ma, S.N.; Ren, Z.P.; Dong, J.Q. 2019: Effect of intervention programs regarding community "5+1" staged diabetes target management on patients with type 2 diabetes mellitus Zhonghua Liu Xing Bing Xue Za Zhi 40(2): 170-174
Mohan, V.; Kalpana, N.; Lakshmipriya, N.; Anitha, P.; Gayathri, R.; Vijayalakshmi, P.; Krishnaswamy, K.; Unnikrishnan, R.; Anjana, R.Mohan.; Vasudevan, S. 2019: A Pilot Study Evaluating the Effects of Diabetes Specific Nutrition Supplement and Lifestyle Intervention on Glycemic Control in Overweight and Obese Asian Indian Adults with Type 2 Diabetes Mellitus Journal of the Association of Physicians of India 67(12): 25-30
Majeed, A.; Newnham, A.; Ryan, R.; Khunti, K. 2002: Prevention and cure of type 2 diabetes. General practitioners are treating more cases of diabetes Bmj 325(7370): 965
Lindström, J.; Neumann, A.; Sheppard, K.E.; Gilis-Januszewska, A.; Greaves, C.J.; Handke, U.; Pajunen, P.; Puhl, S.; Pölönen, A.; Rissanen, A.; Roden, M.; Stemper, T.; Telle-Hjellset, V.; Tuomilehto, J.; Velickiene, D.; Schwarz, P.E.; Acosta, T.; Adler, M.; AlKerwi, A.; Barengo, N.; Barengo, R.; Boavida, J.M.; Charlesworth, K.; Christov, V.; Claussen, B.; Cos, X.; Cosson, E.; Deceukelier, S.; Dimitrijevic-Sreckovic, V.; Djordjevic, P.; Evans, P.; Felton, A-M.; Fischer, M.; Gabriel-Sanchez, R.; Gilis-Januszewska, A.; Goldfracht, M.; Gomez, J.L.; Greaves, C.J.; Hall, M.; Handke, U.; Hauner, H.; Herbst, J.; Hermanns, N.; Herrebrugh, L.; Huber, C.; Hühmer, U.; Huttunen, J.; Jotic, A.; Kamenov, Z.; Karadeniz, S.; Katsilambros, N.; Khalangot, 2010: Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe Hormone and Metabolic Research 42 Suppl. 1: S37-S55
Kleinkauf, H.; Dittmann, J.; Lawen, A. 1991: Cell-free biosynthesis of cyclosporin a and analogues Biomedica Biochimica Acta 50(10-11): S219-S224
Kobayashi, M.; Abiru, N. 2012: Immune-regulation and clinical intervention in type 1 diabetes Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 3): 342-345
Sacks, F.M.; Carey, V.J.; Fruchart, J-Charles. 2010: Combination lipid therapy in type 2 diabetes New England Journal of Medicine 363(7): 692
Ionescu-Tîrgovişte, C.; Gavrilă, L.; Brădescu, O.M.; Guja, C. 2004: NIDDM: new once-daily intervention for type 2 diabetes mellitus: Diaprel MR Romanian Journal of Internal Medicine 42(2): 431-440
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Liu, Z.; Deng, H.; Tang, W-Li. 2003: Mutation of GCK gene of Chinese patients with late-onset type 2 diabetes Hunan Yi Ke Da Xue Xue Bao 28(2): 99-101
Zykina, V.V.; Sharafetdinov, K.K.; Kodentsova, V.M.; Vrzhesinskaia, O.A.; Plotnikova, O.A.; Beketova, N.A.; Pereverzeva, O.G.; Kosheleva, O.V.; Kaganov, B.S. 2008: Vitamin and beta-carotine sufficiency of patients suffering from type 2 diabetes Voprosy Pitaniia 77(5): 33-36
Sharma, A.K.; Agrawal, R.P.; Sharma, J.K.; Agrawal, R.; Kumar, S.; Thackar, K.; Saini, K.C. 2016: Vitamin D: a Critical Micronutrient for Vascular Health in Type 2 Diabetes Mellitus Journal of the Association of Physicians of India 64(7): 28-33
Pozzilli, P.; Signore, A.; Andreani, D. 1986: Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention? Recenti Progressi in Medicina 77(5): 245-248
Sinclair, A.J. 2007: Towards a minimum data set for intervention studies in type 2 diabetes in older people Journal of Nutrition Health and Aging 11(3): 289-93; Discussion 292-3
Kirk, J.K.; Pearce, K.A.; Michielutte, R.; Summerson, J.H. 1999: Troglitazone or metformin in combination with sulfonylureas for patients with type 2 diabetes? Journal of Family Practice 48(11): 879-882
Pinkhasov, B.B.; Seliatitskaia, V.G.; Mitrofanov, I.M.; Anufrienko, A.V.; Dolgova, N.A. 2014: Combination of arterial hypertension and type 2 diabetes mellitus with obesity Klinicheskaia Meditsina 92(9): 65-69
Noda, M. 2002: Primary prevention of diabetes mellitus by pharmacological intervention Nihon Rinsho. Japanese Journal of Clinical Medicine 60 Suppl. 9: 100-108